Please login to the form below

Not currently logged in
Email:
Password:

antbody-drug conjugates

This page shows the latest antbody-drug conjugates news and features for those working in and with pharma, biotech and healthcare.

Merck KGaA furthers antibody ambitions in cancer

Merck KGaA furthers antibody ambitions in cancer

Signs deal with Mersana to develop antibody-drug conjugates. Germany's Merck KGaA is keeping the pressure on its rivals in oncology by signing a deal with US-based biotech Mersana ... Merck, via its biopharma division Merck Serono, will use Mersana's

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Using human insights to push healthcare communications forward
This blog highlights the value of human perspectives, showing how insights can propel healthcare communications forward to ultimately improve lives...
RWE Blog 4: The place of real-world evidence in the market access strategy
The fourth and final blog in our latest series focuses on market access strategy. This follows our evaluation of the role of real-world data (RWD) and real-world evidence (RWE) in...
RWE Blog 3: Is real-world evidence the holy grail
We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...

Infographics